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Abstract
The problems associated with the ageing immune system coupled with possible solutions were
discussed recently at the British Society for Immunology Annual Congress in Harrogate in
December 2004. The session "Ageing and the Immune System in vivo" dealt in details with the
immune risk phenotype and the potential methods of reversing the problems of an ageing immune
system. This is a commentary on that session.
From an early age our immune system is introduced to a
variety of infectious agents through contact with infected
individuals. We also deliberately present our immune
responses either to attenuated organisms or to compo-
nents of infectious pathogens in order to provoke a
response. A successful response to these organisms when
first encountered provides us with immunological mem-
ory to enable our immune systems to make more rapidly
responses to the same potentially infectious agents at a
later date. In theory the longer we live the better our mem-
ory responses and our ability to cope with any potential
pathogen seen previously. Since there are no completely
sterile environments, individuals who have survived to
reach a ripe old age must have combated many possible
infectious agents, and have an immune system with a pro-
digious memory component. Only part of this is true. As
we age the memory component of our immune system, as
measured by the number of memory cells, does increase.
Unfortunately this is not accompanied by improved
immunity even to infectious agents that have been over-
come earlier in life [1-4].
The problems associated with the ageing immune system
coupled with possible solutions were discussed recently at
the British Society for Immunology Annual Congress in
Harrogate in December 2004. The session "Ageing and the
Immune System in vivo" dealt in details with the immune
risk phenotype and the potential methods of reversing the
problems of an ageing immune system.
The concept of the immune risk phenotype was described
by Dr Anders Wikby (Jönköping University) who carried
out a longitudinal immunological study in order to estab-
lish predictive factors for longevity. Dr Anders first worked
on a group of normal octogenarians in the OCTA study in
Sweden which later became the NONA study as these
individuals entered their nineties. Within this group he
was able to describe the immune risk phenotype which he
characterised by a CD4:CD8 ratio of <1, poor in vitro T
cell proliferation, an increase in the number of
CD8+CD28- cells (or CD8+CD28-CD27- in the very old),
low numbers of B cells and the presence of CD8 T cells
which were cytomegalovirus (CMV) tetramer positive.
Within both the OCTO and NONA groups Dr Anders was
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able to show that the immune risk phenotype had some
predictive input towards morbidity. This was even more
apparent when cognitive impairment was included in the
calculations.
The effect of CMV infection on the immune system in the
elderly was also discussed by Professor Paul Moss (Uni-
versity of Birmingham) with particular emphasis on the
clonal expansion of T cells. Clonally expanded T cells are
usually CD8+ and show an increased incidence with age,
so far it seems that clonal expansion is not due to malig-
nant transformation but may follow antigen stimulation.
The control of CMV within the body is mainly attributed
to CD8+ T cells and Professor Moss revealed that in older
individuals up to 50% of CD8+ T cells may be specific for
CMV as judged by tetramer staining. It is possible that this
increased response to CMV may lead to the impairment of
responses to other viruses in the aged. This theme of CMV
infection and ageing was then continued by Professor
Graham Pawelec (University of Tuebingen) who intro-
duced the use of the KLRG-1 marker as a marker of senes-
cence. T cells which are KLRG-1+ do not proliferate in vitro
when provided with a stimulus which would induced pro-
liferation in T cells which lack this marker. In elderly indi-
viduals fewer CMV tetramer positive CD8+ T cells secreted
interferon-γ  in Elispot assays when compared with similar
cells from younger individuals. Furthermore between 96
and 99%of the CD8+ T cells which stained with the CMV
tetramer also expressed the KLRG-1 marker. The theme of
CMV infection in the elderly was further continued by
Professor Arne Akbar (University College London) whose
research group has recently been analyzing telomere
lengths in different T cell subsets using a fluorescent stain-
ing technique. In this method telomeres are stained with
a fluorescently labeled probe and the brighter the fluores-
cent labeling the longer the telomere. Using this tech-
nique Professor Akbar reported that CMV specific CD4+ T
cells in older individuals had very short telomeres indicat-
ing their limited replicative capacity and that more of
these CMV specific CD4+ T cells expressed interferon-γ .
This view of a bleak future for displaying the immune risk
phenotype was countered by the last two presentations
which discussed different approaches to reversing the
defects seen in the immune system with age. Both of these
methods centered around reversing the atrophy of the thy-
mus seen with age. Dr Jayne Sutherland, currently at the
Anthony Nolan Research Institute, detailed her work car-
ried out whilst with Professor Richard Boyd (Monash Uni-
versity) on reversing age associated thymic atrophy by
surgical or chemical castration. Studies in mice revealed
that reversal of thymic atrophy followed surgical castra-
tion and in humans chemical castration produced
changes in the TREC levels which indicated improved
thymic output. Functional studies showed that this treat-
ment improved immune function in the treated aged sub-
jects. This theme of improved immunity following
reversal of thymic atrophy was carried further in work
reported by Dr Richard Aspinall (Imperial College, Lon-
don). He showed how therapeutic intervention with inter-
leukin 7 and derivates could reverse atrophy of the
thymus in old animals and also lead to improved immune
function compared with age and sex matched controls. In
addition he described work done in the Gambia which
suggested a link between the development and enlarge-
ment of the thymus after birth and the level of interleukin
7 in breast milk.
Two speakers from the posters presentations were also
chosen to present their results. K. Wang from Professor
Janet Lord's group (Birmingham) presented work on
dehydroepiandrosterone, (DHEA). This steroid hormone
declines with age and treatment of NK cells with DHEA
increases NK cytotoxicity and further analysis shows that
DHEA induces PKC-β  translocation and upregulates per-
forin expression in these cells. D. Silva from Donald Palm-
ers laboratory (Royal Veterinary College) presented work
on the expression of neuropeptides in epithelial cells from
the thymuses of different species.
The meeting revealed that much needs to be done in char-
acterizing the changes in the immune system which are
associated with ageing, and members of the audience
were asked whether they were interested in receiving more
details about the newly formed "Differentiation and
Immunosenesence Affinity Group" associated with the
BSI.
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